IRD
Financials
- Market Capitalization 306.99 M
- Employee 28
- Founded 2018
- CEO N/A
- Website www.opusgtx.com
- Headquarter Delaware, United States
- FIGI BBG000BT34Q3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3265 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.29 USD | -2.76% | -0.94% | +4.13% | -4.34% | 319.85 M USD | ||
| 3294 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.19 USD | +1.57% | -2.99% | +35.51% | +92.22% | 311.95 M USD | ||
| 3341 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.85 USD | 0.00% | +0.26% | +7.54% | -39.84% | 293.74 M USD | ||
| 3344 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.84 USD | -2.67% | +4.79% | +31.55% | -1.60% | 293.11 M USD |
Frequently asked questions about Opus Genetics, Inc. Common Stock
What is the Opus Genetics, Inc. Common Stock stock price today?
The current price of Opus Genetics, Inc. Common Stock (IRD) is 3.69. Over the past 24 hours, the stock has changed by -4.16%. Follow the IRD chart for real-time price dynamics.
What is the stock ticker of Opus Genetics, Inc. Common Stock?
Opus Genetics, Inc. Common Stock trades under the ticker IRD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Opus Genetics, Inc. Common Stock stock going up?
IRD has changed by -8.21% over the last week, +6.65% over the last month, and -0.81% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Opus Genetics, Inc. Common Stock?
Opus Genetics, Inc. Common Stock currently has a market capitalization of 306.99 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Opus Genetics, Inc. Common Stock earnings last quarter?
Last quarter, Opus Genetics, Inc. Common Stock reported earnings of -0.08 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Opus Genetics, Inc. Common Stock revenue for the last quarter?
Opus Genetics, Inc. Common Stock reported quarterly revenue of 755 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Opus Genetics, Inc. Common Stock net income for the last quarter?
Opus Genetics, Inc. Common Stock reported net income of -8.1 M for the last quarter. The previous quarter showed -65.53 M, which means net income changed by +87.64%.
How many employees does Opus Genetics, Inc. Common Stock have?
As of the latest available data, Opus Genetics, Inc. Common Stock has 28 employees. Workforce size can provide additional context about the company's scale and operations.
What is Opus Genetics, Inc. Common Stock EBITDA?
Opus Genetics, Inc. Common Stock EBITDA is -16.47 M, and its EBITDA margin is -2 180.93%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Opus Genetics, Inc. Common Stock stock?
You can buy Opus Genetics, Inc. Common Stock (IRD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Opus Genetics, Inc. Common Stock stock?
Investing in Opus Genetics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IRD chart and related analysis on metatrader.com as part of your research.